BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26012253)

  • 61. [Inhibition of sciadopitysin against UDP-glucuronosyltransferases].
    Wang XX; Hou J; Ning J; Pan YQ; Hong M; Guo B
    Yao Xue Xue Bao; 2016 May; 51(5):749-55. PubMed ID: 29874021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase.
    Jiang LP; Zhao J; Cao YF; Hong M; Sun DX; Sun XY; Yin J; Zhu ZT; Fang ZZ
    Evid Based Complement Alternat Med; 2014; 2014():594354. PubMed ID: 25530784
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
    Katoh M; Matsui T; Yokoi T
    Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of bergenin.
    Song H; Wang J; Zhang R; Liu X; Yuan G; Wei C; Wang B; Guo R
    Biomed Chromatogr; 2014 Mar; 28(3):348-53. PubMed ID: 23996546
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs).
    Jiang HM; Fang ZZ; Cao YF; Hu CM; Sun XY; Hong M; Yang L; Ge GB; Liu Y; Zhang YY; Dong Q; Liu RJ
    Chemosphere; 2013 Oct; 93(6):1189-93. PubMed ID: 23948605
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deglycosylation of liquiritin strongly enhances its inhibitory potential towards UDP-glucuronosyltransferase (UGT) isoforms.
    Guo B; Fan XR; Fang ZZ; Cao YF; Hu CM; Yang J; Zhang YY; He RR; Zhu X; Yu ZW; Sun XY; Hong M; Yang L
    Phytother Res; 2013 Aug; 27(8):1232-6. PubMed ID: 23065713
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New Insights into SN-38 Glucuronidation: Evidence for the Important Role of UDP Glucuronosyltransferase 1A9.
    Xiao L; Zhu L; Li W; Li C; Cao Y; Ge G; Sun X
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):424-428. PubMed ID: 29076612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.
    Baranczewski P; Kallin A; Andersson A; Hagigi S; Aberg M; Postlind H; Mankowitz L
    Assay Drug Dev Technol; 2004 Aug; 2(4):345-52. PubMed ID: 15357915
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
    Picard N; Ratanasavanh D; Prémaud A; Le Meur Y; Marquet P
    Drug Metab Dispos; 2005 Jan; 33(1):139-46. PubMed ID: 15470161
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In Vitro Comparative Study of the Inhibitory Effects of Mangiferin and Its Aglycone Norathyriol towards UDP-Glucuronosyl Transferase (UGT) Isoforms.
    Sun D; Zhang CZ; Ran RX; Cao YF; Du Z; Fu ZW; Huang CT; Zhao ZY; Zhang WH; Fang ZZ
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28621744
    [TBL] [Abstract][Full Text] [Related]  

  • 71. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of UDP-glucuronosyltransferase isoforms responsible for leonurine glucuronidation in human liver and intestinal microsomes.
    Tan B; Cai W; Zhang J; Zhou N; Ma G; Yang P; Zhu Q; Zhu Y
    Xenobiotica; 2014 Sep; 44(9):775-84. PubMed ID: 24635759
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of UDP-glucuronosyltransferases by different furoquinoline alkaloids.
    Li Y; Zhang W; Yin T; Wang C; Wang F; Sun J; Liu L; Zhang Q; Zhang C
    Xenobiotica; 2020 Oct; 50(10):1170-1179. PubMed ID: 32367776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The inhibitory effects of nor-oleanane triterpenoid saponins from Stauntonia brachyanthera towards UDP-glucuronosyltransferases.
    Liu D; Li S; Qi JQ; Meng DL; Cao YF
    Fitoterapia; 2016 Jul; 112():56-64. PubMed ID: 27223851
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Strong Specific Inhibition of UDP-glucuronosyltransferase 2B7 by Atractylenolide I and III.
    Zhang Q; Cao YF; Ran RX; Li RS; Wu X; Dong PP; Zhang YY; Hu CM; Wang WM
    Phytother Res; 2016 Jan; 30(1):25-30. PubMed ID: 26536846
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
    Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
    Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
    Lu L; Zhou J; Shi J; Peng XJ; Qi XX; Wang Y; Li FY; Zhou FY; Liu L; Liu ZQ
    PLoS One; 2015; 10(5):e0127524. PubMed ID: 26010150
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors.
    Zhou QH; Qin WW; Finel M; He QQ; Tu DZ; Wang CR; Ge GB
    Int J Biol Macromol; 2021 Jun; 180():252-261. PubMed ID: 33741369
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
    Rouguieg K; Picard N; Sauvage FL; Gaulier JM; Marquet P
    Drug Metab Dispos; 2010 Jan; 38(1):40-5. PubMed ID: 19841060
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.
    Xing H; Yang J; Ren K; Qin Z; Wang P; Zhang X; Yao Z; Gonzalez FJ; Yao X
    J Pharm Pharmacol; 2020 Dec; 72(12):1865-1878. PubMed ID: 32750744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.